John W Eaton

Title: John W. Eaton: Innovator in Antigenic Modulation

Introduction

John W. Eaton is a notable inventor based in Houston, Texas, recognized for his contributions to the field of cellular composition and immunology. With a total of two patents to his name, Eaton has made significant strides in developing non-immunogenic cellular compositions that have various medical applications.

Latest Patents

Eaton's latest patents focus on antigenic modulation of cells. The first patent describes a non-immunogenic cellular composition that includes a cell with antigenic determinants on its surface, an optional linker molecule, and a hydrophilic, biocompatible compound such as polyethylene glycol. This invention aims to decrease phagocytosis of cells, reduce adverse reactions to transfusions, and minimize rejection of transplanted cells, tissues, or organs. The second patent also addresses similar concepts, emphasizing the importance of the linker molecule in camouflaging antigenic determinants to enhance the efficacy of the cellular composition.

Career Highlights

Eaton is affiliated with Albany Medical College, where he continues to advance his research and innovations in the field of immunology. His work has the potential to significantly impact medical treatments and improve patient outcomes.

Collaborations

Eaton collaborates with Mark D. Scott, contributing to the advancement of their shared research interests and enhancing the scope of their innovations.

Conclusion

John W. Eaton's work in antigenic modulation represents a significant advancement in the field of immunology. His innovative patents and collaborations continue to pave the way for future developments in non-immunogenic cellular therapies.